Evidence map›Paper›PMID 23684565›Full record

ArticleNitric oxide : biology and chemistry2013

Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.

Bahar Tunctan, Belma Korkmaz, Ayse Nihal Sari, Meltem Kacan, Demet Unsal, Mehmet Sami Serin, C Kemal Buharalioglu, Seyhan Sahan-Firat, Tuba Cuez, Wolf-Hagen Schunck and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Nitric oxide : biology and chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Molecular mechanisms in septic shock (Review).Experimental and therapeutic medicine · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. MORG1BMC nephrology · 2018
    Article
  13. Article
  14. Article
  15. Inflammasomes: Pandora's box for sepsis.Journal of inflammation research · 2018
    Review
  16. Article
  17. Article
  18. Simvastatin prevents lipopolysaccharide-induced septic shock in rats.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Bahar TunctanDepartment of Pharmacology, Faculty of Pharmacy, Mersin University, 33169 Mersin, Turkey. tunctanb@yahoo.com
Belma Korkmaz
Ayse Nihal Sari
Meltem Kacan
Demet Unsal
Mehmet Sami Serin
C Kemal Buharalioglu
Seyhan Sahan-Firat
Tuba Cuez
Wolf-Hagen Schunck
Vijaya L Manthati
John R Falck
Kafait U Malik
Mersin Üniversitesi · TRThe University of Texas Southwestern Medical Center · USMax Delbrück Center · DEUniversity of Tennessee Health Science Center · US

Funding

TRANSPORT EFFECTS OF ARACHIDONATE METABOLITES IN PERFUSED TUBULEP01DK038226 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BROWN, NANCY J. · 1986 to 2015
$22.1M
Angiotensins, Prostaglandins and Adrenergic InteractionsR01HL019134 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KAFAIT U MALIK · 1985 to 2026
$14.7M
NHLBI NIH HHS R01 HL019134NIDDK NIH HHS DK38226NIDDK NIH HHS P01 DK038226PHS HHS 19134-37
6 · The paper itself

Abstract

We have previously demonstrated that a stable synthetic analog of 20-hydroxyeicosatetraenoic acid (20-HETE), N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine (5,14-HEDGE), prevents vascular hyporeactivity, hypotension, tachycardia, and inflammation in rats treated with lipopolysaccharide (LPS) and mortality in endotoxemic mice. These changes were attributed to decreased production of inducible nitric oxide (NO) synthase (iNOS)-derived NO, cyclooxygenase (COX)-2-derived vasodilator prostanoids, and proinflammatory mediators associated with increased cyctochrome P450 (CYP) 4A1-derived 20-HETE and CYP2C23-dependent antiinflammatory mediator formation. The aim of this study was to determine whether decreased expression and activity of iNOS, soluble guanylyl cyclase (sGC), protein kinase G (PKG), COX-2, gp91(phox) (NOX2; a superoxide generating NOX enzyme), and peroxynitrite production associated with increased expression of COX-1 and CYP4A1 and 20-HETE formation in renal and cardiovascular tissues of rats contributes to the effect of 5,14-HEDGE to prevent vasodilation, hypotension, tachycardia, and inflammation in response to systemic administration of LPS. Mean arterial pressure fell by 28mmHg and heart rate rose by 47beats/min in LPS (10mg/kg, i.p.)-treated rats. Administration of LPS also increased mRNA and protein expression of iNOS and COX-2 associated with a decrease in COX-1 and CYP4A1 mRNA and protein expression. Increased NOS activity, iNOS-heat shock protein 90 complex formation (an index for iNOS activity), protein expression of phosphorylated vasodilator stimulated phosphoprotein (an index for PKG activity), gp91(phox), p47(phox) (NOXO2; organizer subunit of gp91(phox)), and nitrotyrosine (an index for peroxynitrite production) as well as cGMP (an index for sGC activity), 6-keto-PGF1α (a stable metabolite PGI2) and PGE2 levels (indexes for COX activity), and nitrotyrosine levels by LPS were also associated with decreased CYP hydroxylase activity as measured by 20-HETE formation from arachidonic acid in renal microsomes of LPS-treated rats. These effects of LPS, except iNOS mRNA and COX-1 protein expression, were prevented by 5,14-HEDGE (30mg/kg, s.c.; 1h after LPS). A competitive antagonist of vasoconstrictor effects of 20-HETE, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (30mg/kg, s.c.; 1h after LPS) reversed the effects of 5,14-HEDGE, except iNOS and COX-1 mRNA and protein expression as well as expression of CYP4A1 mRNA. These results suggest that increased CYP4A1 expression and 20-HETE formation associated with suppression of iNOS/sGC/PKG pathway, COX-2, and gp91(phox) participate in the protective effect of 5,14-HEDGE against vasodilation, hypotension, tachycardia, and inflammation in the rat model of septic shock.

Indexed as

AnimalsCell Adhesion MoleculesCyclic GMP-Dependent Protein KinasesCyclooxygenase 2Cytochrome P-450 CYP2J2Cytochrome P-450 Enzyme SystemDisease Models, AnimalGuanylate CyclaseHSP90 Heat-Shock ProteinsHydroxyeicosatetraenoic AcidsLipopeptidesLipopolysaccharidesMaleMembrane GlycoproteinsMicrofilament ProteinsNADPH Oxidase 220-hydroxyeicosa-6(Z),15(Z)-dienoic acidCell Adhesion MoleculesCybb protein, ratCyclic GMP-Dependent Protein KinasesCyclooxygenase 2Cyp2c23 protein, ratCytochrome P-450 CYP2J2Cytochrome P-450 Enzyme SystemGuanylate CyclaseHSP90 Heat-Shock ProteinsHydroxyeicosatetraenoic AcidsLipopeptidesLipopolysaccharidesMembrane GlycoproteinsMicrofilament ProteinsN-(20-hydroxyeicosa-5,14-dienoyl)glycineNADPH Oxidase 2NADPH OxidasesNitric Oxide Synthase Type IINos2 protein, ratPeroxynitrous AcidPhosphoproteinsProtective AgentsReceptors, Cytoplasmic and NuclearRNA, MessengerSoluble Guanylyl CyclaseVasodilator-Stimulated Phosphoprotein1,3-PBIT20-HEDE20-HETE20-hydroxyeicosa-6(Z),15(Z)-dienoic acid20-hydroxyeicosatetraenoic acid5,14-HEDGEAAarachidonic acidcDNAcGMPcomplementary deoxyribonucleic acidCOXCOX-2cyclic guanosine monophosphatecyclooxygenasecyctochrome P450CYPCYP4A1EETELISAendothelial nitric oxide synthaseEndotoxineNOSenzyme-linked immunosorbent assayepoxyeicosatrienoic acidERKextracellular signal-regulated kinasegp91(phox)/NOX2heart rateheat shock proteinHRhspHypotensionIKKILinducible nitric oxide synthaseinhibitor of κBiNOSiNOS/sGC/PKG pathwayinterleukinintraperitoneallyi.p.IκBIκB kinaselipopolysaccharideLPSMAPMAPKmean arterial pressureMEKmessenger ribonucleic acidmitogen-activated protein kinasemitogen-activated protein kinase kinase 1mRNAN-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycineNADPHNF-κBnicotinamide adenine dinucleotide phosphatenitric oxideNOnuclear factor-κBPGphenylene-1,3-bis(ethane-2-isothiourea) dihydrobromidephosphorylated vasodilator stimulated phosphoproteinPKGprostaglandinprotein kinase Gp-VASPreverse transcription-polymerase chain reactionRT-PCRs.c.sEHsGCsoluble epoxide hydrolasesoluble guanylyl cyclasesubcutaneouslyTNFtumor necrosis factorvasodilator stimulated phosphoproteinVASP

Identifiers

PMID23684565
PMCPMC3759626
OpenAlexW2083441422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.